fbpx

Joshua M. Tarnoff

Chief Executive Officer

Josh Tarnoff joined NephCure as CEO in early 2018, fulfilling a long-held desire to serve the rare disease patient community more closely. He spent more than 30 years working in the pharmaceutical and biotechnology community, moving new therapies closer to reality. Personal connections with NephCure families fuels his passion to achieve NephCure’s mission-driven goals, and he always appreciates directly speaking with our community. Josh also has personal insights into renal disease as he was once a patient, likely a result of a snake bite. He lives in Pennsylvania, where he enjoys backpacking — while also trying to avoid further contact with venomous snakes.

+